This inventor holds 3 USPTO granted patents. Top assignees: Astrazeneca Ab, Astra Aktiebolag. Active years: 2001-2002.
Company Filing History:
Years Active: 2001-2002
Title: The Innovations of Lena Hedström
Introduction
Lena Hedström is a notable inventor based in Täby, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on crystalline forms of various compounds. With a total of 3 patents to her name, Hedström's inventions have enhanced the stability and efficacy of important pharmaceutical substances.
Latest Patents
Hedström's latest patents include a substantially crystalline form of melagatran. This invention demonstrates that crystalline forms of melagatran exhibit high chemical and solid-state stability compared to their amorphous counterparts. Another significant patent involves the compound EtO C—CH—(R)Cgl—Aze—Pab—OH, or a pharmaceutically acceptable salt thereof, which also showcases the advantages of crystalline forms in terms of stability.
Career Highlights
Throughout her career, Lena Hedström has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Astra Aktiebolag. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in drug formulation and stability.
Collaborations
Hedström has collaborated with several talented individuals in her field, including Anita Lundblad and Daniel Edvardsson. These partnerships have fostered a creative environment that has led to the successful development of her patented inventions.
Conclusion
Lena Hedström's contributions to the pharmaceutical industry through her innovative patents highlight her expertise and dedication to improving drug stability. Her work continues to influence the field and pave the way for future advancements.